LUCINDA SMITH: Open Payments
NPI 1487124616 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$799 in 28 payments from 13 companies in 2025. Trend: 2023 $395 · 2024 $1,038 · 2025 $799
Food & beverage: $797Education: $2
| Company | Payments | Amount |
|---|---|---|
| AKEBIA THERAPEUTICS INC | 2 | $245 |
| Travere Therapeutics, Inc. | 9 | $167 |
| Mallinckrodt Hospital Products Inc. | 3 | $74 |
| ANI Pharmaceuticals, Inc. | 2 | $62 |
| GlaxoSmithKline, LLC. | 2 | $38 |
| Aurinia Pharma U.S., Inc. | 2 | $37 |
| SCPHARMACEUTICALS INC. | 2 | $36 |
| Novartis Pharmaceuticals Corporation | 1 | $34 |
| Apellis Pharmaceuticals, Inc. | 1 | $26 |
| Calliditas Therapeutics US Inc. | 1 | $23 |
Products named: Vafseo, TERLIVAZ, PURIFIED CORTROPHIN GEL, SHINGRIX, LUPKYNIS, FUROSCIX, Fabhalta, Empaveli.
Industry payments across SC — which companies pay providers there.
